###begin article-title 0
Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 378 385 <span type="species:ncbi:10325">B virus</span>
The Coxsackie and adenovirus receptor (CAR) has a restricted expression pattern in the adult. In skeletal muscle, although CAR is expressed in immature fibers, its transcript levels are barely detectable in mature muscle. This is in contrast to the robust expression observed in the heart. However, both heart and skeletal muscle are susceptible to infection with the Coxsackie B virus which utilizes primarily CAR for cellular internalization. The specific point of viral entry in skeletal and heart muscle remains unknown.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
Using antibodies directed against the extracellular and the cytoplasmic domains of CAR, we show CAR in normal human and mouse skeletal muscle to be a novel component of the neuromuscular junction. In cardiac muscle, CAR immunoreactivity is observed at the level of intercalated discs. We demonstrate a single isoform of CAR to be expressed exclusively at the human neuromuscular junction whereas both predominant CAR isoforms are expressed at the intercalated discs of non-diseased human heart.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 232 239 <span type="species:ncbi:10325">B virus</span>
The localization of CAR to these important junctional complexes suggests that CAR may play both a structural and a regulatory role in skeletal and cardiac muscle, and that these complexes may serve as a point of entry for Coxsackie B virus.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 47 48 47 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 580 581 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 684 685 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 395 398 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 426 429 <span type="species:ncbi:29256?0.7272727272727273">TVV</span>
###xml 874 880 <span type="species:ncbi:9606">humans</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 894 900 <span type="species:ncbi:9606">humans</span>
###xml 1084 1089 <span type="species:ncbi:10090">mouse</span>
The Coxsackie and adenovirus receptor (CAR) [1,2], a transmembrane protein of the immunoglobulin super-family, serves as a receptor for adenovirus (Ad) subgroups A, C, D, E and F [3] as well as Coxsackie B viruses (CVB) [4]. CAR is a highly conserved protein with two predominant isoforms, produced through differential splicing, and having cytoplasmic domains of either 107 residues (ending in SIV) or 94 residues (ending in TVV) [2,5]. The extracellular domain mediates homophilic cell adhesion [6-8] and ectopically-expressed CAR localizes to homotypic intercellular contacts [8]. The expression of CAR is regulated developmentally [6,9-12] as well as in a tissue-specific manner [2,5]. To date, most studies on CAR expression in the adult have resorted to analysis of transcript levels. These have revealed that the pattern of tissue-specific expression differs between humans and mice. In humans, a predominant transcript of ~6 - 6.5 kb is observed in heart, testis, prostate and pancreas while much less expression is detected in liver, brain, colon and small intestine. In the mouse on the other hand, the most abundant expression is in liver, kidney, lung and heart.
###end p 9
###begin p 10
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 589 598 589 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1487 1489 1487 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1732 1734 1732 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1817 1819 1817 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1888 1889 1888 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1890 1891 1890 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1899 1900 1899 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 270 285 <span type="species:ncbi:10090">transgenic mice</span>
###xml 914 921 <span type="species:ncbi:10325">B virus</span>
###xml 931 937 <span type="species:ncbi:9606">humans</span>
###xml 1394 1399 <span type="species:ncbi:9606">human</span>
###xml 1400 1408 <span type="species:ncbi:9606">patients</span>
###xml 1875 1878 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 1882 1885 <span type="species:ncbi:29256?0.7272727272727273">TVV</span>
Interest in CAR stems from its function as the primary high affinity receptor for Ad serotype 5, the most commonly used adenoviral vector in gene therapy protocols. CAR expression is the main determinant in gene transfer to normal tissue as ectopic expression of CAR in transgenic mice leads to several magnitudes of increase in adenovirus transducibility of tissues that are otherwise refractory to Ad-mediated gene expression [13-17]. As well, although decay accelerating factor (DAF, CD55) was the first described CVB receptor [18,19], CAR is necessary and sufficient for CVB infection in vitro [20]. Thus, the expression levels of CAR may also govern the susceptibility to CVB diseases and the pathological consequences of CVB viral infection. In this context, acute viral myocarditis and myositis are inflammatory diseases affecting cardiac and skeletal muscle that can result from infection by the Coxsackie B virus. In both humans and rodents, heart is among the tissues showing the greatest abundance of CAR transcript while its transcripts are barely detectable in skeletal muscle even with the more sensitive reverse-transcriptase (RT)-PCR-based assay [21]. In contrast to heart, DAF expression is absent in mature skeletal muscle [22]. Despite the absence of DAF and low CAR transcript levels, skeletal muscle is nevertheless susceptible to Coxsackie virus-induced myositis. Indeed, human patients suffering from inflammatory muscle diseases have tested positive for CBV RNA [23]. This suggests that the low CAR transcript level in skeletal muscle may produce functional receptor. Therefore, to examine CAR localization in skeletal and cardiac muscle, we used antibodies directed against the extracellular domain of CAR [21] as well as antibodies that can differentiate between the two major CAR isoforms [24] with alternate 3' splicing [ending in the amino acids SIV or TVV] [2,5] [Fig. 1].
###end p 10
###begin p 11
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Depiction of the CAR sequences recognized by the anti-C-terminal antibodies. </bold>
###xml 81 88 <span type="species:ncbi:9031">chicken</span>
###xml 223 229 <span type="species:ncbi:9986">rabbit</span>
###xml 371 377 <span type="species:ncbi:9986">rabbit</span>
###xml 440 446 <span type="species:ncbi:10090">murine</span>
Depiction of the CAR sequences recognized by the anti-C-terminal antibodies. The chicken antibody ChCT was raised against a fusion protein containing C-terminal sequence common to both CAR isoforms (from aa 259 - 339). The rabbit antibodies (RP291 and RP194) were raised against peptides that were specific to each isoform. The diagram does not show the immunogen of the rabbit antibody 2240 which is the extracellular N-terminal domain of murine CAR. Note that each antibody has a distinct recognition sequence. TM - transmembrane sequence.
###end p 11
###begin title 12
Results and Discussion
###end title 12
###begin p 13
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 671 672 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 838 840 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 908 910 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 1185 1187 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1335 1337 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1489 1493 1485 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 1521 1523 1517 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1537 1539 1533 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 304 307 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 323 326 <span type="species:ncbi:29256?0.7272727272727273">TVV</span>
###xml 420 425 <span type="species:ncbi:9606">human</span>
###xml 581 587 <span type="species:ncbi:10090">murine</span>
###xml 780 783 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 860 863 <span type="species:ncbi:29256?0.7272727272727273">TVV</span>
###xml 1238 1243 <span type="species:ncbi:10090">mouse</span>
###xml 1493 1498 <span type="species:ncbi:10090">mouse</span>
To immunolocalize CAR, frozen sections of normal human muscle biopsies were probed with polyclonal antibodies raised against the extracellular domain of CAR [21] [ab 2240], or against the cytoplasmic tail, antibodies which specifically recognize the two predominant isoforms of human CAR (referred to as SIV [ab RP291] and TVV [ab RP194] respectively) [24]. We localized CAR exclusively to the neuromuscular junction in human skeletal muscle (Fig. 2) where CAR immunoreactivity coincided with acetylcholine receptors as revealed by alpha-bungarotoxin binding. Similarly, in mature murine skeletal muscle, CAR expression was restricted to the neuromuscular junction (Fig. 3). Interestingly, we find CAR expression at the neuromuscular junction to be isoform specific, with the CAR SIV isoform accounting for all CAR immunoreactivity (Fig. 2G). In contrast, the TVV isoform is present in the vasculature (Fig. 2I). CAR is therefore identified as a novel component of the adult neuromuscular junction, joining other homotypic cell adhesion molecules such as N-cadherin and neural cell adhesion molecule (N-CAM) which have been localized previously to this specialized site. As with NCAM [25], although CAR is uniformly expressed in immature mouse muscle (data not shown), its expression becomes downregulated within a few weeks of birth [21] and its localization is confined to the neuromuscular junction. As well, in skeletal muscle undergoing regeneration, as is the case in the dystrophic mdx mouse, CAR is re-expressed [21] as is NCAM [26].
###end p 13
###begin p 14
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunolocalization of CAR to the neuromuscular junction in human skeletal muscle</bold>
###xml 244 246 240 242 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 250 252 246 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 354 356 346 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 413 415 405 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 500 502 492 494 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E </bold>
###xml 559 561 551 553 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 652 654 644 646 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 675 677 667 669 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 681 682 673 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 690 692 682 684 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F </bold>
###xml 713 715 705 707 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 719 720 711 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 736 740 728 732 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C, F</bold>
###xml 878 879 866 867 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1026 1027 1014 1015 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1070 1071 1058 1059 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1151 1152 1139 1140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
Immunolocalization of CAR to the neuromuscular junction in human skeletal muscle. Frozen sections of human muscle were incubated with Alexa Fluor-conjugated alpha-bungarotoxin and antibodies to CAR as described in Materials and Methods. Panels A and D show alpha-bungarotoxin staining of acetylcholine receptors at neuromuscular junctions (green). Panel B shows immunofluorescent staining of the section in panel A with a polyclonal antibody (ab 2240) to the extracellular domain of CAR (red). Panel E shows immunofluorescent staining of the section in panel D with a mixture of the isoform-specific C-terminal antibodies RP194 and RP 291 (red). Panel C is a merge of panels A and B. Panel F is a merge of panels D and E. These merges [C, F] show that CAR colocalizes with alpha-bungarotoxin at neuromuscular junctions (in yellow). Of the two C-terminal antibodies, only RP291 (G) demonstrates the typical neuromuscular junction staining while signal is absent when sections are incubated under similar conditions with RP194 (H) although RP194 does label blood vessels (I). Sections incubated with secondary antibody alone did not reveal any signals (J). Bar = 25 mum (A, D); 50 mum (G, I).
###end p 14
###begin p 15
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunolocalization of CAR to the neuromuscular junction in mouse skeletal muscle</bold>
###xml 244 246 240 242 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 250 252 246 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 354 356 346 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 413 415 405 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 500 502 492 494 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E </bold>
###xml 559 561 551 553 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 692 694 684 686 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 715 717 707 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 721 722 713 714 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 730 732 722 724 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F </bold>
###xml 753 755 745 747 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 759 760 751 752 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 776 780 768 772 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C, F</bold>
###xml 977 978 965 966 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 999 1000 987 988 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 568 575 <span type="species:ncbi:9031">chicken</span>
###xml 835 841 <span type="species:ncbi:10090">murine</span>
###xml 965 971 <span type="species:ncbi:9986">rabbit</span>
###xml 986 993 <span type="species:ncbi:9031">chicken</span>
Immunolocalization of CAR to the neuromuscular junction in mouse skeletal muscle. Frozen sections of mouse muscle were incubated with Alexa Fluor-conjugated alpha-bungarotoxin and antibodies to CAR as described in Materials and Methods. Panels A and D show alpha-bungarotoxin staining of acetylcholine receptors at neuromuscular junctions (green). Panel B shows immunofluorescent staining of the section in panel A with a polyclonal antibody (ab 2240) to the extracellular domain of CAR (red). Panel E shows immunofluorescent staining of the section in panel D with a chicken polyclonal antibody (ChCT) directed against a C-terminal portion of CAR conserved in both CAR isoforms (red). Panel C is a merge of panels A and B. Panel F is a merge of panels D and E. These merges [C, F] show that CAR colocalizes with alpha-bungarotoxin at murine neuromuscular junctions (in yellow). Sections incubated with the secondary antibodies alone did not give any signal - anti-rabbit IgG [G], anti-chicken IgY [H]. Bar = 35 mum
###end p 15
###begin p 16
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 87 93 <span type="species:ncbi:10090">murine</span>
###xml 190 193 <span type="species:ncbi:10116">rat</span>
###xml 299 302 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 307 310 <span type="species:ncbi:29256?0.7272727272727273">TVV</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
###xml 492 498 <span type="species:ncbi:10090">murine</span>
###xml 548 554 <span type="species:ncbi:10090">murine</span>
###xml 724 727 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 732 735 <span type="species:ncbi:29256?0.7272727272727273">TVV</span>
###xml 774 780 <span type="species:ncbi:10090">murine</span>
###xml 860 866 <span type="species:ncbi:9986">rabbit</span>
###xml 946 953 <span type="species:ncbi:9031">chicken</span>
CAR has been suggested to serve as a structural component at the intercalated discs in murine cardiac muscle [8] and recently confirmed to reside primarily at the intercalated discs in both rat heart and neonatal cultured cardiomyocytes of the rodent [12]. Using antibodies directed to the specific SIV and TVV isoforms of the receptor as described above, we localized CAR to the intercalated discs (Fig. 4), demonstrating for the first time expression of both receptor isoforms in human and murine heart. To confirm the presence of both isoforms, murine cardiac muscle homogenates were analyzed by SDS-PAGE followed by electrotransfer to nitrocellulose membranes. This immunoblot analysis revealed the presence of both the SIV and TVV isoforms (Fig. 5A). Furthermore, when murine cardiac muscle homogenates were immunoprecipitated with either RP194 or RP 291 rabbit polyclonal antibodies, Western blot analysis of the resultant fractions with a chicken antibody against CAR C-terminal domain showed a single 46 kDa band (Fig. 5B), confirming the specificity of the antibodies for CAR.
###end p 16
###begin p 17
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunolocalization of CAR to intercalated discs in human and murine cardiac muscle. </bold>
###xml 91 95 91 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, B</bold>
###xml 109 113 109 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C, D</bold>
###xml 206 210 206 210 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, C</bold>
###xml 223 227 223 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B, D</bold>
###xml 314 318 314 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, B</bold>
###xml 351 355 351 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C, D</bold>
###xml 392 393 392 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 426 427 426 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 61 67 <span type="species:ncbi:10090">murine</span>
###xml 84 89 <span type="species:ncbi:9606">Human</span>
###xml 101 107 <span type="species:ncbi:10090">murine</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
###xml 324 330 <span type="species:ncbi:10090">murine</span>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 403 409 <span type="species:ncbi:10090">murine</span>
###xml 474 480 <span type="species:ncbi:9986">rabbit</span>
Immunolocalization of CAR to intercalated discs in human and murine cardiac muscle. Human [A, B] and murine [C, D] cardiac muscle sections were reacted with the polyclonal anti-C-terminal antibodies RP194 [A, C] and RP291 [B, D]. Note the intense staining of both isoforms at the human intercalated discs (arrow) [A, B] and murine intercalated discs [C, D]. Neither the human cardiac tissue [E] nor the murine cardiac muscle [F] gave any signal when incubated with the anti-rabbit IgG. Bar = 10 mum (A, E); 30 mum (C, F).
###end p 17
###begin p 18
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Murine cardiac muscle homogenates express both isoforms of CAR. </bold>
###xml 64 67 64 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 278 281 277 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 281 287 <span type="species:ncbi:10090">Murine</span>
###xml 419 426 <span type="species:ncbi:9031">chicken</span>
###xml 653 659 <span type="species:ncbi:9986">rabbit</span>
Murine cardiac muscle homogenates express both isoforms of CAR. A. Immunoblot analysis of cardiac muscle homogenates (10 mug) reveals that a single polypeptide of 46 kDa is detected by the anti-C-terminal antibodies recognizing the two different CAR isoforms (RP194 and RP291). B. Murine cardiac homogenates were immunoprecipitated with either RP194 (lanes 1,2) or RP291 (lanes 3,4) followed by immunoblotting with the chicken ChCT antibody that recognizes the C-terminal portion of CAR that is common to both isoforms. The ChCT antibody detected as a single band the increasing amounts of CAR that was immunoprecipitated with increasing amounts of the rabbit polyclonal antibodies (2 mul, lanes 1,3; 4 mul, lanes 2,4).
###end p 18
###begin p 19
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 887 888 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 717 720 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 725 728 <span type="species:ncbi:29256?0.7272727272727273">TVV</span>
Both of the cytoplasmic variants contain a PDZ recognition motif at their distal end, implicating CAR as a putative member of multiprotein complexes. This is indeed the case in polarized epithelial cells in which CAR is expressed at the tight junction where it associates with the tight junction scaffolding protein ZO-1 [8] and contributes to maintenance of transepithelial resistance. The localization of CAR to cardiac intercalated discs is in agreement with CAR having a structural or regulatory role as a transmembrane member of junctional complexes. The intercalated discs are composed of at least three structurally distinct cellular junctions - desmosomes, the adherens junctions, and gap junctions [27]. The SIV and TVV isoforms may localize to separate components of the intercalated disc, or given that CAR has been implicated as a transmembrane component in tight junctions [8], both isoforms may be localized to the adherens junction, a structure analogous to tight junctions.
###end p 19
###begin p 20
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
It is interesting that a correlation can be drawn between disease incidence and expression levels of the CAR receptor. Cases of viral myocarditis in the human population outnumber those of myositis. This may be attributable to the difference of endogenous CAR expression between the two tissues. Considering that induction of CAR accompanies myocarditis [28] and its dramatic upregulation has recently been demonstrated in patients suffering from multiple diseases of the heart [29] including dilated cardiomyopathy, a pathological phenotype linked to persistent acute myocarditis, upregulation of the receptor may render the heart even more susceptible to further viral infection. Conversely, the low level of endogenous CAR expression in skeletal muscle may safeguard against the wide-spread viral infection seen in myocarditis and may be responsible for the less severe clinical features of myositis.
###end p 20
###begin title 21
Conclusions
###end title 21
###begin p 22
###xml 359 366 <span type="species:ncbi:10325">B virus</span>
CAR is a novel member of the neuromuscular junction. In cardiac muscle, both CAR isoforms are found at the intercalated discs. The localization of CAR to these important junctional complexes suggests that CAR may play both a structural and a regulatory role in skeletal and cardiac muscle, and that these complexes may serve as a point of entry for Coxsackie B virus.
###end p 22
###begin title 23
Methods
###end title 23
###begin title 24
Antibodies
###end title 24
###begin p 25
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 692 693 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 164 170 <span type="species:ncbi:9986">rabbit</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 670 675 <span type="species:ncbi:9606">human</span>
###xml 858 863 <span type="species:ncbi:10090">mouse</span>
Figure 1 depicts the sequences used as immunogen to generate the various antibodies. There was no overlap (i.e. common epitopes) between any of the antibodies. The rabbit polyclonal antibodies used in this study were described previously [21,24]. Briefly, the N-terminal polyclonal antibody (ab 2240) was prepared against a His-tagged fusion protein which encoded amino acid residues 22-208 of the extracellular domain of mouse CAR [21]. This antiserum cross-reacts with human CAR on Western blots and in indirect immunofluorescence. The two C-terminal polyclonal antibodies [24] were generated using peptides encompassing the last 13 amino acids of the two predominant human CAR isoforms [2,5]. Antiserum RP194 was raised against the sequence FKYAYKTDGITVV while RP291 was raised against the sequence VMIPAQSKDGSIV. Both these antisera cross-react with the mouse CAR homologs (the peptides are conserved 100% between the two species [30]). All antisera were affinity purified prior to use.
###end p 25
###begin p 26
###xml 13 20 <span type="species:ncbi:9031">chicken</span>
###xml 297 305 <span type="species:ncbi:9031">chickens</span>
###xml 395 403 <span type="species:ncbi:9031">chickens</span>
To raise the chicken anti-CAR antibody (ChCT), purified His-tagged fusion protein encoding the C-terminal portion of CAR that is common to both isoforms (amino acids 259-339) was emulsified in an equal volume of TiterMax Gold adjuvant (CytRx Corp., Norcross, GA) and injected intramuscularly into chickens. One month post-injection, IgY antibodies to CAR were obtained from the eggs of injected chickens and subjected to affinity purification.
###end p 26
###begin title 27
Immunocytochemistry
###end title 27
###begin p 28
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 144 150 <span type="species:ncbi:10090">murine</span>
###xml 432 438 <span type="species:ncbi:9913">bovine</span>
###xml 521 526 <span type="species:ncbi:10090">mouse</span>
###xml 532 538 <span type="species:ncbi:9986">rabbit</span>
Immunolabelling was performed using standard techniques. Briefly, frozen sections (5 mum) of normal human skeletal and cardiac muscle biopsies, murine skeletal and cardiac muscle were fixed in 2% paraformaldehyde (pH 6.8) for 1-2 minutes, followed by overnight incubation at 4degreesC with the primary antibodies (a 1:30 dilution was used for ab 2240, and 1:200 dilution for the abs RP291 and RP194, in blocking solution made of 3% bovine serum albumin and 0.05% Tween-20 in phosphate-buffered saline). Incubation with a mouse anti-rabbit biotin-conjugated secondary ab (1:120; Jackson Immunoresearch Laboratories, West Grove, PA) was followed by Cy-3-conjugated streptavidin (1:1000; Jackson Immunoresearch Laboratories). Controls consisted of sections treated in the absence of primary antibody. Neuromuscular junctions were revealed with Alexa-488-conjugated-alpha-bungarotoxin [alpha BTX] (1:40) (Molecular Probes, Eugene, OR). Slides were viewed on a Leica microscope-based imaging system using OpenLab imaging software (Quorum Technologies, St Catharines, ON).
###end p 28
###begin title 29
Western blot analysis and immunoprecipitation
###end title 29
###begin p 30
###xml 712 716 <span type="species:ncbi:9925">goat</span>
###xml 722 728 <span type="species:ncbi:9986">rabbit</span>
Cardiac muscle tissue was homogenized in extraction buffer [1% Triton X-100; 0.1 mM EDTA; 0.1 mM EGTA; 50 mM Tris-HCl; pH 8.0; with protease inhibitors (Roche)] at 4degreesC. After a 30 second sonication, samples were centrifuged at 3000 x g for 30 seconds at 4degreesC. Protein samples (10 mug) were anayzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 10% (w/v) polyacrylamide gels, followed by electrotransfer to nitrocellulose. The blots were blocked in 10% BLOTTO (skim milk powder) in Tris buffered saline - Tween 20 (TBS-T) for 45 minutes at room temperature. Anti-CAR antibody was added in 10% BLOTTO at a dilution of 1:2500. Following incubation with peroxidase-labeled goat-anti-rabbit secondary antibody (Jackson Immunoresearch Laboratories), the signal was visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech, Baie d'Urfe, QC).
###end p 30
###begin p 31
###xml 484 491 <span type="species:ncbi:9031">chicken</span>
###xml 639 645 <span type="species:ncbi:9793">donkey</span>
###xml 651 658 <span type="species:ncbi:9031">chicken</span>
Immunoprecipitation was carried out on cardiac muscle homogenates that had been pre-cleared with Protein-A Agarose slurry (Sigma), followed by overnight incubation at 4degreesC with RP291 or RP194. The samples were further incubated with Protein-A Agarose for 2 hours, washed twice with extraction buffer and then eluted with 2 X Laemmli SDS sample buffer with 5% mercaptoethanol. Following SDS-PAGE and electrotransfer, nitrocellulose membranes were probed with a primary polyclonal chicken anti-CAR (ChCT) in blocking solution (diluted 1:500) overnight at 4degreesC. Signal was revealed following incubation with a peroxidase-conjugated donkey anti-chicken IgY (Jackson Immunoresearch Laboratories) at a dilution of 1:2500 for 40 minutes, and enhanced chemiluminescence.
###end p 31
###begin title 32
Authors' contributions
###end title 32
###begin p 33
CAS performed the immunoprecipitation, the immunoblotting, participated in the immunofluorescent staining experiments and drafted the manuscript. PCH and JN conceived the study, participated in its design and interpretation as well as drafting the manuscript. CA participated in the immunofluorescent staining experiments. KS prepared and characterized the isoform-specific antibodies. MS and GK participated in the design and interpretation of the studies. All authors read and approved the final manuscript.
###end p 33
###begin title 34
Acknowledgements
###end title 34
###begin p 35
This work was supported by a grant from the Canadian Institutes of Health Research and the Muscular Dystrophy Association (USA). J. N. is a National Research Scholar of the FRSQ and a Killam Scholar.
###end p 35
###begin article-title 36
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
###end article-title 36
###begin article-title 37
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
###end article-title 37
###begin article-title 38
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F
###end article-title 38
###begin article-title 39
###xml 155 184 <span type="species:ncbi:12075">swine vesicular disease virus</span>
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus
###end article-title 39
###begin article-title 40
###xml 4 10 <span type="species:ncbi:10090">murine</span>
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
###end article-title 40
###begin article-title 41
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain
###end article-title 41
###begin article-title 42
###xml 39 44 <span type="species:ncbi:9606">human</span>
CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta
###end article-title 42
###begin article-title 43
The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction
###end article-title 43
###begin article-title 44
Developmental distribution of coxsackie virus and adenovirus receptor localized in the nervous system
###end article-title 44
###begin article-title 45
Expression of the adenovirus receptor and its interaction with the fiber knob
###end article-title 45
###begin article-title 46
Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism
###end article-title 46
###begin article-title 47
###xml 68 71 <span type="species:ncbi:10116">rat</span>
###xml 151 154 <span type="species:ncbi:10116">rat</span>
Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat
###end article-title 47
###begin article-title 48
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for adenovirus gene delivery
###end article-title 48
###begin article-title 49
Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells
###end article-title 49
###begin article-title 50
Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle
###end article-title 50
###begin article-title 51
Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic model
###end article-title 51
###begin article-title 52
###xml 16 21 <span type="species:ncbi:9606">human</span>
Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes
###end article-title 52
###begin article-title 53
###xml 0 17 <span type="species:ncbi:12072">Coxsackievirus B3</span>
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
###end article-title 53
###begin article-title 54
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment
###end article-title 54
###begin article-title 55
###xml 46 63 <span type="species:ncbi:12072">coxsackievirus B3</span>
A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells
###end article-title 55
###begin article-title 56
Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells
###end article-title 56
###begin article-title 57
###xml 81 86 <span type="species:ncbi:9606">human</span>
Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers
###end article-title 57
###begin article-title 58
Dermatomyositis, polymyositis, and Coxsackie-B-virus infection
###end article-title 58
###begin article-title 59
The Coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX)
###end article-title 59
###begin article-title 60
Expression of several adhesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin, and a heparan sulfate proteoglycan) in embryonic, adult, and denervated adult skeletal muscle
###end article-title 60
###begin article-title 61
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Expression of NCAM and its polysialylated isoforms during mdx mouse muscle regeneration and in vitro myogenesis
###end article-title 61
###begin article-title 62
Dilated cardiomyopathy: a disease of the intercalated disc?
###end article-title 62
###begin article-title 63
###xml 66 70 <span type="species:ncbi:10116">rats</span>
Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis
###end article-title 63
###begin article-title 64
###xml 53 58 <span type="species:ncbi:9606">human</span>
Coxsackie-and-adenovirus receptor mRNA expression in human heart failure
###end article-title 64
###begin article-title 65
Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers
###end article-title 65

